|
Re: Outstanding shares
|
1
|
Resverlogix Corp.
|
Jan 23, 2019 12:32PM
|
|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 05:56PM
|
|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 02:24PM
|
|
Re: Question for the board!
|
2
|
Zenith Epigenetics
|
Jan 22, 2019 12:46PM
|
|
Re: Question for the board!
|
3
|
Zenith Epigenetics
|
Jan 22, 2019 12:30PM
|
|
Question for the board!
|
1
|
Zenith Epigenetics
|
Jan 22, 2019 11:11AM
|
|
Re: Rothschild Engagement – What’s the Strategy?
|
2
|
Resverlogix Corp.
|
Jan 20, 2019 12:47PM
|
|
Re: ... just for whatever reason...
|
3
|
Zenith Epigenetics
|
Jan 19, 2019 11:47PM
|
|
Re: ... just for whatever reason...
|
2
|
Zenith Epigenetics
|
Jan 19, 2019 11:45AM
|
|
Re: ... just for whatever reason...
|
2
|
Zenith Epigenetics
|
Jan 19, 2019 09:38AM
|
|
Re: ... just for whatever reason...
|
3
|
Zenith Epigenetics
|
Jan 18, 2019 07:40AM
|
|
Re: ... just for whatever reason...
|
3
|
Zenith Epigenetics
|
Jan 17, 2019 05:47PM
|
|
Re: 50 day moving average is $3.18
|
1
|
Resverlogix Corp.
|
Jan 17, 2019 08:56AM
|
|
Re: 50 day moving average is $3.18
|
|
Resverlogix Corp.
|
Jan 17, 2019 07:07AM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 10, 2019 10:36AM
|
|
Re: How long would the last enrolled patient have to be in the trail before their stats would be included.
|
2
|
Resverlogix Corp.
|
Jan 10, 2019 04:27AM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 05:54PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 03:43PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
4
|
Resverlogix Corp.
|
Jan 09, 2019 02:49PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 02:07PM
|
